1.
|
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019- nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020;79:104212.
|
2.
|
World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). (2020-01-30) [2020-02-02].
|
3.
|
Chen Z, Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res 2004;18(7):592–4.
|
4.
|
Lai L, Han X, Chen H, Wei P, Huang C, Liu S, et al. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase. Cur Pharm Des 2006;12(35):4555–64.
|
5.
|
Wang SQ, Du QS, Zhao K, Li AX, Wei DQ, Chou KC. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids 2007;33 (1):129–35.
|
6.
|
Kesel AJ. Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS). Curr Med Chem 2005;12 (18):2095–162.
|
7.
|
Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 2004;101(27):10012–7.
|
8.
|
Liu B, Zhou J. SARS-CoV protease inhibitors design using virtual screening method from natural products libraries. J Comput Chem 2005;26(5):484–90.
|
9.
|
Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L, Tolstikov GA, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 2005;48(4):1256–9.
|
10.
|
Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005;67(1):18–23.
|
11.
|
Chen L, Li J, Luo C, Liu H, Xu W, Chen G, et al. Binding interaction of quercetin- 3-b-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg Med Chem 2006;14(24):8295–306.
|
12.
|
Park JY, Yuk HJ, Ryu HW, Lim SH, Kim KS, Park KH, et al. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem 2017;32(1):504–15.
|
13.
|
Bhoj VG, Chen ZJ. Ubiquitylation in innate and adaptive immunity. Nature 2009;458(7237):430–7.
|
14.
|
Bhoj VG, Chen ZJ. Ubiquitylation in innate and adaptive immunity. Nature 2009;458(7237):430–7.
|
15.
|
Mukherjee P, Shah F, Desai P, Avery M. Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. J Chem Inf Model 2011;51(6):1376–92.
|
16.
|
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450–4.
|
17.
|
Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 2007;50 (17):4087–95.
|
18.
|
Ryu YB, Park SJ, Kim YM, Lee JY, Seo WD, Chang JS, et al. SARS-CoV 3CLpro inhibitory effects of quinine methide triterpenes from Tripterygium regelii. Bioorg Med Chem Lett 2010;20(6):1873–6.
|
19.
|
Park JY, Kim JH, Kim YM, Jeong HJ, Kim DW, Park KH, et al. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg Med Chem 2012;20(19):5928–35.
|
20.
|
Park JY, Kim JH, Kwon JM, Kwon HJ, Jeong HJ, Kim YM, et al. Dieckol, a SARSCoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg Med Chem 2013;21(13):3730–7.
|
21.
|
Song YH, Kim DW, Curtis-Long MJ, Yuk HJ, Wang Y, Zhuang N, et al. Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. Biol Pharm Bull 2014;37(6):1021–8.
|
22.
|
Park JY, Ko JA, Kim DW, Kim YM, Kwon HJ, Jeong HJ, et al. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem 2016;31(1):23–30.
|
23.
|
Shen L, Niu J, Wang C, Huang B, Wang W, Zhu N, et al. High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J Virol 2019;93(12):e00023–e119.
|
24.
|
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 [Epub ahead of print].
|
25.
|
Amir Hassan & Himayat Ullah 2019. Antibacterial and Antifungal Activities of the Medicinal Plant Veronica biloba. Journal of Chemistry, 2019, 7.
|
26.
|
Amir Hassan, Zakarya Akmal, and Himayat Ullah 2020. The Phytochemical Screening and Antioxidants Potential of Schenoplectus Triqueter L Palla. Journal of Chemistry, 2020.
|
27.
|
Hu W, Fu W, Wei X, Yang Y, Lu C, Liu Z. A network pharmacology study on the active ingredients and potential targets of Tripterygium wilfordii Hook for treatment of rheumatoid arthritis. Evid Based Complement Alternat Med 2019;2019:5276865.
|
28.
|
Amir Hassan 2020. Traditional Chinese Herbal Medication for CORONA-VIRUS 2019. Journal of Travel Medicine and Infectious Disease, 36, 2020, 1-2
|